Lipoprotein(a) and Calcific Aortic Valve Stenosis Progression: A Systematic Review and Meta-Analysis.


Journal

JAMA cardiology
ISSN: 2380-6591
Titre abrégé: JAMA Cardiol
Pays: United States
ID NLM: 101676033

Informations de publication

Date de publication:
17 Jul 2024
Historique:
medline: 17 7 2024
pubmed: 17 7 2024
entrez: 17 7 2024
Statut: aheadofprint

Résumé

There are currently no pharmacological treatments available to slow hemodynamic progression of aortic stenosis. Plasma lipoprotein(a) concentrations predict incident aortic stenosis but its association with hemodynamic progression is controversial. To determine the association between plasma lipoprotein(a) concentrations and hemodynamic progression in patients with aortic stenosis. The study included patients with aortic stenosis from 5 longitudinal clinical studies conducted from March 2001 to March 2023 in Canada and the UK. Of 757 total patients, data on plasma lipoprotein(a) concentrations and rates of hemodynamic progression assessed by echocardiography were available for 710, who were included in this analysis. Data were analyzed from March 2023 to April 2024. Cohort-specific plasma lipoprotein(a) concentration tertiles. Hemodynamic aortic stenosis progression on echocardiography as assessed by annualized change in peak aortic jet velocity, mean transvalvular gradient, and aortic valve area. Among the included patients, 497 (70%) were male and 213 (30%) were female. The mean (SD) age was 65.2 (13.1) years. Patients in the top lipoprotein(a) tertile demonstrated 41% (estimate, 1.41; 95% CI, 1.13-1.75) faster progression of peak aortic jet velocity and 57% (estimate, 1.57; 95% CI, 1.18-2.10) faster progression of mean transvalvular gradient than patients in the bottom tertile. There was no evidence of heterogeneity across the individual cohorts. Progression of aortic valve area was comparable between groups (estimate, 1.23; 95% CI, 0.71-2.12). Similar results were observed when plasma lipoprotein(a) concentrations were treated as a continuous variable. In this study, higher plasma lipoprotein(a) concentrations were associated with faster rates of hemodynamic progression in patients with aortic stenosis. Lowering plasma lipoprotein(a) concentrations warrants further investigation in the prevention and treatment of aortic stenosis.

Identifiants

pubmed: 39018080
pii: 2820718
doi: 10.1001/jamacardio.2024.1882
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Benoit J Arsenault (BJ)

Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec, Université Laval, Québec, Canada.
Department of Medicine, Faculty of Medicine, Université Laval, Québec, Québec, Canada.

Krithika Loganath (K)

Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom.

Arnaud Girard (A)

Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec, Université Laval, Québec, Canada.

Simona Botezatu (S)

Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom.
University of Medicine and Pharmacy Carol Davila, Cardiology Department, Euroecolab, Bucharest, Romania.

Kang H Zheng (KH)

Department of Vascular Medicine, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
Department of Cardiology, Onze Lieve Vrouwe Gasthuis Hospital, Amsterdam, the Netherlands.

Evangelos Tzolos (E)

Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom.

Kathia Abdoun (K)

Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec, Université Laval, Québec, Canada.

Lionel Tastet (L)

Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec, Université Laval, Québec, Canada.

Romain Capoulade (R)

Nantes Université, Centre hospitalier universitaire Nantes, Centre national de recherche scientifique, Institut national de la santé et de la recherche médicale, l'institut du thorax, Nantes, France.

Nancy Côté (N)

Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec, Université Laval, Québec, Canada.

Neil Craig (N)

Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom.

Kwan L Chan (KL)

Department of Medicine, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.

James W Tam (JW)

Department of Medicine, St Boniface General Hospital, Winnipeg, Manitoba, Canada.

Koon K Teo (KK)

Department of Medicine (Cardiology), McMaster University, Hamilton, Ontario, Canada.

Christian Couture (C)

Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec, Université Laval, Québec, Canada.

Marie-Annick Clavel (MA)

Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec, Université Laval, Québec, Canada.
Department of Medicine, Faculty of Medicine, Université Laval, Québec, Québec, Canada.

Patrick Mathieu (P)

Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec, Université Laval, Québec, Canada.
Department of Surgery, Faculty of Medicine, Université Laval, Québec, Québec, Canada.

Sébastien Thériault (S)

Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec, Université Laval, Québec, Canada.
Department of Molecular Biology, Medical Biochemistry and Pathology, Faculty of Medicine, Université Laval, Québec, Québec, Canada.

Erik S G Stroes (ESG)

Department of Vascular Medicine, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands.

David E Newby (DE)

Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom.

Sotirios Tsimikas (S)

Division of Cardiovascular Diseases, Department of Medicine, University of California, San Diego, La Jolla.

Philippe Pibarot (P)

Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec, Université Laval, Québec, Canada.
Department of Medicine, Faculty of Medicine, Université Laval, Québec, Québec, Canada.

Marc R Dweck (MR)

Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom.

Classifications MeSH